Long-Term Changes in Complete Blood Count-Derived Inflammatory Indices During Risankizumab Treatment for Psoriasis: A 208-Week Multicenter Real-World Study.
Overview & Synopsis
Open access biomedical research article published in Antibodies (Basel).
Indexed from repository: PubMed Central
(
pmc.ncbi.nlm.nih.gov)
Keyboard Shortcuts:
← / → for pages • + / - for zoom • 0 to fit width
Powered by Mozilla PDF.js v3.11
Document Information
| Document Title | Long-Term Changes in Complete Blood Count-Derived Inflammatory Indices During Risankizumab Treatment for Psoriasis: A 208-Week Multicenter Real-World Study. |
|---|---|
| Author / Organization | Balestri R, Pallanch C, Magnano M, Colombini J, Clarizio G, Bardazzi F, Di Lernia V, Satolli F, Ganzetti G, Buligan C, Mazzoletti V, Pacetti L, Odorici G, Borghi A, Saraceno R, Mengarino M, Gisondi P, Girolomoni G, Lacava R, Rech G, Bellinato F |
| Subject & Discipline | Antibodies (Basel) |
| Categories | Medicine & Health |
| Publication Year | 2026 |
| License / Rights | Open Access / Creative Commons |
| Resource Verification | Listed PDF (Verification Pending) |
| Original Host Website |
PubMed Central
(pmc.ncbi.nlm.nih.gov)
|
| File Format | application/pdf (Portable Document Format) |
| Language | EN |
| Catalog ID | DOC-134096 |
| Original Source Link | Visit Source Page on pmc.ncbi.nlm.nih.gov » |